MYH9 disorder: Identification and a novel mutation in patients with macrothrombocytopenia
The diagnosis of MYH9 disorder is guided by recognizing granulocyte Döhle body-like inclusion bodies and large/giant platelets in the peripheral blood smear. Immunofluorescence study of nonmuscle myosin heavy chain IIA is a sensitive screening method for diagnosis of MYH9 disorder. The diagnosis can...
Saved in:
Main Authors: | Rungrote Natesirinilkul, Darintr Sosothikul, Patcharee Komwilaisak, Bunchoo Pongtanakul, Nattee Narkbunnum, Najwa Yudhasompop, Pimsiri Mekjarusgool, Pimjai Niparuck, Kochawan Boonyawat, Shinji Kunishima, Nongnuch Sirachainan, Somjai Kanjanapongkul, Thirachit Chotsampancharoen, Chanchai Trivaree, Siranee Wongruangsri, Pacharapan Surapolchai, Sumonmaln Klamchuen, Saranya Busakornruangrat, Kittima Kanchanakamhaeng, Nattaporntira Phalakornkul |
---|---|
Other Authors: | Siriraj Hospital |
Format: | Article |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/78048 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
The first two cases of MYH9 disorders in Thailand: an international collaborative study
by: Nongnuch Sirachainan, et al.
Published: (2018) -
Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes
by: Bunchoo Pongtanakul, et al.
Published: (2020) -
Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes
by: Bunchoo Pongtanakul, et al.
Published: (2020) -
Outcome of childhood acute lymphoblastic leukemia treated using the thai national protocols
by: Panya Seksarn, et al.
Published: (2018) -
Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: A prospective multicenter study
by: Piya Rujkijyanont, et al.
Published: (2020)